Halozyme Therapeutics shares owned by Pacer Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pacer Advisors
from 13F filings
Historical chart of Pacer Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Pacer Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $35M | 479k | 73.34 |
| 2025-06-30 | $1.2M | 22k | 52.02 |
| 2025-03-31 | $740k | 12k | 63.81 |
| 2024-12-31 | $1.4M | 29k | 47.81 |
| 2024-09-30 | $1.7M | 29k | 57.24 |
| 2024-03-31 | $1.1M | 28k | 40.68 |
| 2023-12-31 | $975k | 26k | 36.96 |
| 2023-09-30 | $425k | 11k | 38.20 |
| 2023-06-30 | $1.2M | 33k | 36.07 |
| 2023-03-31 | $317k | 8.3k | 38.19 |
| 2022-12-31 | $1.5M | 26k | 56.90 |
| 2022-09-30 | $233k | 5.9k | 39.53 |
| 2021-12-31 | $600k | 15k | 40.24 |
| 2021-09-30 | $795k | 20k | 40.66 |
| 2021-06-30 | $630k | 14k | 45.38 |
| 2021-03-31 | $656k | 16k | 41.67 |
| 2020-12-31 | $494k | 12k | 42.67 |
| 2020-09-30 | $121k | 4.6k | 26.27 |
| 2018-09-30 | $123k | 6.8k | 18.18 |
| 2017-12-31 | $43k | 2.1k | 20.24 |